Skip to main content
. 2016 Nov 3;6(11):e013086. doi: 10.1136/bmjopen-2016-013086

Table 4.

Univariate analysis displaying correlations of the predefined determinants to EQ-5D dimensions and EQ VAS

EQ-5D
 EQ VAS
MO
 SC
 UA
 PD
 AD
N Corr.coef p Value Corr.coef p Value Corr.coef p Value Corr.coef p Value Corr.coef p Value Corr.coef p Value
Age 213 0.09 0.19 0.05 0.49 0.07 0.32 0.06 0.39 0.06 0.38 −0.06 0.31
Sex 213 −0.20* <0.05 −0.03 0.70 −0.23* <0.05 −0.13* 0.06 −0.27* <0.05 0.23* <0.05
6MWT 213 −0.43* <0.05 −0.28* <0.05 −0.42* <0.05 −0.30* <0.05 −0.25* <0.05 0.51* <0.05
BMI 213 0.13* 0.06 0.14* 0.04 0.10 0.16 0.03 0.71 0.05 0.50 0.22* <0.05
BNP 203 0.19* 0.01 0.01 0.89 0.15* 0.03 0.13* 0.07 0.19* 0.01 −0.10 0.14
Ongoing AC 213 0.09 0.19 −0.05 0.45 0.02 0.73 0.02 0.80 −0.01 0.85 −0.06 0.38
Cardiopulmonary comorbidity 213 0.15* 0.03 0.05 0.47 0.17* 0.01 0.09 0.20 0.06 0.20 −0.19* 0.01
Active cancer 213 0.09 0.20 0.01 0.99 0.01 0.90 −0.01 0.93 0.01 0.97 −0.02 0.77
Reporting dyspnoea 213 0.16* 0.02 0.13* 0.05 0.29* <0.05 0.40* <0.05 0.11 0.11 −0.37* <0.05
F-score 192 0.06 0.42 0.15* 0.04 0.11 0.13 0.07 0.36 −0.01 0.94 −0.12* 0.09
Recurrent VTE 213 0.01 0.93 −0.06 0.35 −0.02 0.73 0.06 0.35 −0.01 0.95 −0.02 0.77
Unemployed 213 0.10 0.13 0.08 0.27 0.22* <0.05 0.24* <0.05 0.27* <0.05 −0.24* 0.01
Disease duration 213 −0.02 0.77 −0.02 0.79 −0.03 0.64 −0.04 0.58 −0.07 0.32 0.13* 0.05

*All values with α<0.10 retained for multiple regression analysis, explanatory variables recoded to 0=not having the condition and 1=having the condition, dimensions dichotomised in reporting problems=1 and not reporting problems=0.

6MWT, 6 min walking test; AD, anxiety and depression; Age, age at inclusion, male sex=1; BMI, body mass index (kg/m2); BNP, brain natriuretic peptide; Corr. coef, Spearman's r correlation coefficient; EQ-5D, EuroQol five-dimension; EQ VAS, EuroQol visual analogue scale; F-score, Fredrikstad radiological score (higher scores associated with a more proximal location of the thrombus); MO, mobility; Ongoing AC, ongoing anticoagulant treatment; PD, pain and discomfort; SC, self-care; UA, usual activities; Unemployed, unemployed or unemployment because of long-term illness or disability retirement and disease duration=time in years from PE diagnosis to study inclusion.